The unsung conductor of your metabolism GLP-1 (Glucagon-Like Peptide-1) is a gut hormone produced by L cells in your small and large intestines in response to food intake
It enhances insulin release after eating, while reducing the release of glucagon, a hormone that raises blood sugar
Filler-Free Retatrutide Research Guide Understand what filler-free means, what HPLC and mass spectrometry can show, and how to evaluate a lot-specific COA without conflating purity, identity, and content
Red flag: Severe persistent nausea or vomiting after every meal
By addressing fatigue and promoting a spirited, lively lifestyle, this treatment makes aging gracefully a reality under the guidance of our trusted experts
All clinical trials Protocol number: 00008478 Pilot Randomized Controlled Trial of Use of a Website about Radioactive Iodine Symptom Management in Patients with Thyroid Cancer Protocol number: 022-REDUCLN-002 Efficacy of the COronary SInus Reducer in Patients with Refractory Angina II (COSIRA-II) Protocol number: 1305-0031 An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) (FIBRONEER-ON) Protocol number: 1397-0014 A Phase III, randomized, double-blind, placebo-controlled study to assess the Efficacy, Safety, and Tolerability of BI 1291583 2.5 mg administered once daily for up to 76 weeks in patients with Bronchiectasis (The AIRTIVITY Study) Protocol number: 2008-363 Older Breast Cancer Patients: Risk for Cognitive Decline Protocol number: 2013-0496 A cross-over pilot study of the effect of amiloride compared to triamterene on proteinuria in patients with proteinuric kidney disease Protocol number: 2014-0755 Identifying children with diabetes type 1 at high risk for cardiovascular disease Protocol number: 2017-0478 STEPs to Blood Pressure Reduction
